首页 › 基金 › Latash Investments, LLC › ANAB
Latash Investments, LLC 对 ANAB 的持仓历史
ANAPTYSBIO INC · 医疗保健
Latash Investments, LLC 在 Q3 2026 的 13F 申报中披露持有 ANAB(ANAPTYSBIO INC)4,393 股,市值约 US$221K,约占其申报组合的 0.16%,在其申报持仓中市值排名第 18 位。 Latash Investments, LLC 最近 4 个申报季度中有 4 个季度披露了 ANAB 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Latash Investments, LLC 对 ANAB 的持仓演变
Latash Investments, LLC 于 Q4 2025 首次披露 ANAB 持仓:4,393 股(约 US$213K)。 该持仓在 Q2 2026 达到峰值 4,393 股,市值约 US$297K。 在 4 次申报中,Latash Investments, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 4,393 股、市值约 US$221K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 4.39K | $212.97K | 新进 |
| Q1 2026 | 4.39K | $243.64K | 持有 |
| Q2 2026 | 4.39K | $296.53K | 持有 |
| Q3 2026 | 4.39K | $220.79K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANAB 与 13F 数据
ANAB(ANAPTYSBIO INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 ANAB,申报仓位最大的包括:EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANAB 的基金
- EcoR1 Capital, LLC 7.88M 股 · $531.91M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.33M 股 · $89.83M · Q2 2026
- Affinity Asset Advisors, LLC 826.11K 股 · $55.76M · Q2 2026
- 683 Capital Management, LLC 660.00K 股 · $44.55M · Q2 2026
- Sanofi 821.92K 股 · $41.31M · Q3 2026
- Palo Alto Investors LP 603.49K 股 · $40.74M · Q2 2026
- First Light Asset Management, LLC 582.00K 股 · $39.29M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 497.00K 股 · $33.55M · Q2 2026
- Sofinnova Investments, Inc. 493.54K 股 · $33.31M · Q2 2026
- Pertento Partners LLP 545.00K 股 · $27.39M · Q3 2026
- Coppell Advisory Solutions LLC 3.64K 股 · $16.58M · Q2 2026
- Greenhaven Road Investment Management, L.P. 171.06K 股 · $11.55M · Q2 2026
更多关于 Latash Investments, LLC
常见问题
How long has Latash Investments, LLC held ANAB?
Latash Investments, LLC has disclosed ANAB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Latash Investments, LLC's current position in ANAB?
As of Q3 2026, Latash Investments, LLC holds 4.39K shares of ANAB (ANAPTYSBIO INC), valued at $220.79K, representing 0.16% of its reported portfolio and ranking #18.
Has Latash Investments, LLC been buying or selling ANAB?
In the latest 13F filing (Q3 2026), Latash Investments, LLC held unchanged its position in ANAB. The position peaked in Q2 2026 at 4.39K shares.
Which other funds hold ANAB?
Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.